LIPOCINE
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of several hormones for use in men and women health; and various respiratory products for cough and cold conditions. The company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. It also offers custom drugs for pharmaceutical/biotechnology companies. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
LIPOCINE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1997-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.lipocine.com
Total Employee:
11+
Status:
Active
Contact:
8019947383
Email Addresses:
[email protected]
Total Funding:
66.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.lipocine.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.93 K
- Host name: 50-87-168-111.unifiedlayer.com
- IP address: 50.87.168.111
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Lipocine"
Home - Lipocine
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery …See details»
Lipocine Investor Room - Company Profile
Oct 31, 2024 · We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.See details»
Company - Lipocine
Innovative Pharmaceutical Products ENHANCING HEALTH & IMPROVING PATIENT COMPLIANCE. Become Part of The Change. AboutSee details»
Lipocine Investor Room - Press Releases
Sep 30, 2024 · We improve compliance, absorption, and more with our proprietary drug delivery technology. Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its …See details»
Careers - Lipocine
Lipocine Inc. is a Clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies. Lipocine's clinical development …See details»
Lipocine - Crunchbase Company Profile & Funding
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily focuses on developing oral versions of …See details»
Lipocine Investor Room - Presentations
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery …See details»
Lipocine Inc. - LinkedIn
Lipocine Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. The company develops drugs based on Hydroance, a drug delivery technology. It primarily...See details»
Company Lipocine Inc. - MarketScreener.com
Dec 31, 2012 · Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated …See details»
Lipocine Company Profile - Office Locations, Competitors, …
Oct 29, 2024 · Lipocine has 5 employees across 2 locations and ($2.85 m) in annual revenue in FY 2023. See insights on Lipocine including office locations, competitors, revenue, financials, …See details»
Lipocine - Products, Competitors, Financials, Employees, …
Lipocine is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. Use the CB Insights Platform to explore Lipocine's full profile.See details»
Lipocine Announces Senior Leadership Appointments to Advance …
SALT LAKE CITY, Nov. 3, 2022 / PRNewswire / -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating CNS disorders by leveraging its proprietary …See details»
Lipocine Announces Financial Results for the Third Quarter Ended ...
Nov 10, 2021 · Lipocine Inc. is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies. Lipocine's clinical …See details»
Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase …
Nov 13, 2023 · Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that results of its Phase 2 …See details»
Lipocine Announces Financial Results for the Third Quarter Ended ...
Sep 30, 2023 · SALT LAKE CITY, Nov. 8, 2023 / PRNewswire / -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) …See details»
Lipocine Announces Strategic Realignment and Forward Focus on …
Sep 26, 2022 · Company to apply its proprietary Lip'ral oral drug delivery technology to advance a pipeline of differentiated products for Central Nervous System (CNS) disorders. Initial focus on …See details»
Lipocine Announces Financial Results for the Year Ended …
Dec 31, 2021 · SALT LAKE CITY, March 9, 2022 / PRNewswire / -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on neuroendocrine and metabolic …See details»
Lipocine Announces Senior Leadership Appointments to Advance …
SALT LAKE CITY, Nov. 3, 2022 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating CNS disorders by leveraging its proprietary …See details»
Pipeline - Lipocine
Lipocine pipeline products are based on its proprietary solubilization technology for effective oral delivery of water insoluble drugs to improve patient compliance.See details»
Lipocine Announces Financial Results for the Second Quarter …
Aug 8, 2022 · Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on developing innovative products to treat metabolic and central nervous system ("CNS") …See details»